510(k) Report

510(k) · Cleared

Cleared

TSH-CTK-3 Irma

K041014510(k) TraditionalCleared Jul 14, 200485-day reviewClass II21 CFR 862.1690

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

DiaSorin, Inc. · JLW Radioimmunoassay, Thyroid-Stimulating Hormone

Cleared on Jul 14, 2004 as substantially equivalent to K920856 (Hycor Biomedical, Inc., 1992) after an 85-day review. Its family tree reaches back 1 generation to 1992.

Decided
Jul 14, 2004
Review
85 days
Class
Class II
Product code
JLW
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K920856 (1992). No later device cites it as a predicate yet.

K920856 · Ventrex Coated Tube High Sensit. TSH Radioimmunoas · Hycor Biomedical, Inc. · 19921990199520002005
  1. Root · 1 generation backK920856 Ventrex Coated Tube High Sensit. TSH RadioimmunoasHycor Biomedical, Inc. · 1992
  2. This deviceK041014 TSH-CTK-3 IrmaDiaSorin, Inc. · 2004
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K920856Ventrex Coated Tube High Sensit. TSH RadioimmunoasHycor Biomedical, Inc.1992—
0 (this device)K041014TSH-CTK-3 IrmaDiaSorin, Inc.2004—
FIG. 1 — Lineage of K041014, 1992–2004Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JLW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JLW device

  1. #1 K251543 Atellica® IM TSH3-Ultra II (TSH3ULII)score 11.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K920856Ventrex Coated Tube High Sensit. TSH Radioimmunoas
Summary page 2
…3 510(k) Premarket Notification 73 TECHNOLOGICAL COMPARISON TO PREDICATE: Feature Ventrex hTSH "'IIRMA (K920856) TSH-CTK-3 Analyte Thyroid Stimulating Hormone(hTSH) Thyroid Stimulating Hormone (hTSH)…
Hycor Biomedical, Inc.1992—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All JLW devices

JLW Radioimmunoassay, Thyroid-Stimulating Hormone: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JLW

1in 2025

2008: 52009: 22010: 12012: 12013: 12014: 12015: 32016: 32017: 42019: 12022: 12023: 12024: 22025: 12026 (partial year): 1
2007high 5 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JLW

194in 2017

2008: 143 days median2015: 142 days median2016: 238 days median2017: 194 days median
2007high 238 (2016) · low 142 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JLW

2in 2025

2007: 12010: 12011: 12012: 32016: 12018: 42019: 12020: 22024: 22025: 2
2007high 4 (2018) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JLW

103in 2025

2007: 192008: 102009: 412010: 342011: 1672012: 1442013: 1682014: 1552015: 2032016: 1832017: 2352018: 2492019: 2162020: 1452021: 1462022: 1372023: 1622024: 1692025: 103
2007high 249 (2018) · low 10 (2008)2025

MAUDE reports naming product code JLW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—119
20085143010
20092—041
20101—134
20110—1167
20121—3144
20131—0168
20141—0155
201531420203
201632381183
201741940235
20180—4249
20191—1216
20200—2145
20210—0146
20221—0137
20231—0162
20242—2169
20251—2103
20261—0—

What is it indicated for?

The DiaSorin TSH-CTK-3 is an imlunoradiometric assay for the quantitative determination of thyrotropin (TSH) in human serum. Measurements of TSH levels are used as an aid in the diagnosis of thyroid or pituitary disorders.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K041014: TSH-CTK-3 Irma.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K041014

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026